Developing a Down Syndrome Health Instrument

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04631237
Collaborator
National Institutes of Health (NIH) (NIH)
676
1
59.9
11.3

Study Details

Study Description

Brief Summary

Although over 200,000 individuals with DS live in the United States, studies to date have focused on outcomes apart from health. The foundation for this proposal is based on the need to accurately measure health of all individuals - specifically, with DS - and the dearth of available tools for this population. Creating such an instrument will provide a barometer of the current state of health for DS and hold use in future research. In this project, I propose to create an instrument that directly assesses health in DS - the Down syndrome Health Instrument (DHI). More specifically, the aims of this proposal are: 1. To conduct focus groups among caregivers, individuals with DS, panels of experts on DS and primary care physicians, and cognitive interviews to refine a conceptual model of health for DS and create an item pool, 2. To administer the DHI and establish internal validity, reliability, and external validity of the DHI for use in clinical research, and 3. To test the usability of the DHI in two pilot settings: research and clinical. This instrument will measure patient-reported health in DS for the first time and allow measurement of health as an outcome which is not currently possible in this population. This can identify gaps in care, then direct and optimize interventions that will improve care.

Condition or Disease Intervention/Treatment Phase
  • Other: Observational, no intervention

Study Design

Study Type:
Observational
Anticipated Enrollment :
676 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Developing a Down Syndrome Health Instrument
Actual Study Start Date :
Apr 3, 2020
Anticipated Primary Completion Date :
Mar 31, 2025
Anticipated Study Completion Date :
Mar 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Focus Groups

N=52

Other: Observational, no intervention
No intervention involved

Cognitive Interviews

N=24

Other: Observational, no intervention
No intervention involved

Survey

N=600

Other: Observational, no intervention
No intervention involved

Outcome Measures

Primary Outcome Measures

  1. Survey results, cognitive interviews, and validation [Within 12 months of completion of analysis of surveys]

    Local and national survey results, cognitive interviews and validation of DHI

Secondary Outcome Measures

  1. Focus group results and conceptual model [Within 12 months of completion of focus groups]

    Descriptive focus group results regarding health views. Outline of the preliminary conceptual model

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary caregiver of an individual with DS (individual with DS age: <22 years)

  • Caregiver age: ≥18 years

  • Fluent in written and spoken English

  • Able to read and provide informed consent

Exclusion Criteria:
  • Physical or mental condition of caregiver that would prohibit self-administration of questionnaire

  • Mosaic Down syndrome: based on medical record review. If caregiver is uncertain or mosaicism is unknown, we will request additional records.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital
  • National Institutes of Health (NIH)

Investigators

  • Principal Investigator: STEPHANIE L SANTORO, MD, MGH

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stephanie Santoro, Assistant Professor of Pediatrics, Clinical Geneticist, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT04631237
Other Study ID Numbers:
  • 2020P000213
First Posted:
Nov 17, 2020
Last Update Posted:
Nov 17, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Stephanie Santoro, Assistant Professor of Pediatrics, Clinical Geneticist, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 17, 2020